• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

氯法齐明致瘤型麻风并发结肠癌患者出现腹腔内晶体贮积性组织细胞增多症

Intra-abdominal, crystal-storing histiocytosis due to clofazimine in a patient with lepromatous leprosy and concurrent carcinoma of the colon.

作者信息

Pais Anthony V, Pereira Savio, Garg Isha, Stephen John, Antony Meryl, Inchara Y K

机构信息

Department of Surgery, St John's Medical College Hospital, Sarjapur Road, Koramangala, Bangalore, India.

出版信息

Lepr Rev. 2004 Jun;75(2):171-6.

PMID:15282969
Abstract

We report a case with abdominal complications of clofazimine treatment which included blackish discolouration of the lymph nodes, omentum and peritoneum. A 44-year-old female with lepromatous leprosy and a history of adverse reaction to clofazimine 2 years previously, presented with rectosigmoid junction adenocarcinoma. Laparotomy revealed an inoperable tumour with pigmentation of the bowel, serosa and peritoneum. A second operation had o be performed for transverse loop colostomy and a mesenteric lymph node biopsy sent for frozen section showed typical clofazimine crystals. Despite widespread use for many years in the treatment of leprosy, this drug is not known to be carcinogenic and this case provides no evidence for an association or link between its use and the patient's cancer. Apart from its use in leprosy, clofazimine may be used in the treatment of disseminated Mycobacterium avium-intracellulare infection, Buruli ulcer due to M. ulcerans and occasionally in other mycobacterial infections. An awareness of the rare side-effect described above may help in the clinical assessment and management of such cases, including the avoidance of unnecessary laparotomy.

摘要

我们报告了一例氯法齐明治疗引起腹部并发症的病例,这些并发症包括淋巴结、大网膜和腹膜出现黑色色素沉着。一名44岁女性,患有瘤型麻风,2年前有氯法齐明不良反应史,现患有直肠乙状结肠交界处腺癌。剖腹探查发现肿瘤无法切除,肠管、浆膜和腹膜有色素沉着。第二次手术进行了横袢结肠造口术,送检的肠系膜淋巴结活检冰冻切片显示有典型的氯法齐明晶体。尽管氯法齐明多年来广泛用于麻风病治疗,但尚无证据表明其具有致癌性,该病例也未提供其使用与患者癌症之间存在关联的证据。除用于麻风病治疗外,氯法齐明还可用于治疗播散性鸟分枝杆菌复合群感染、溃疡分枝杆菌引起的布鲁里溃疡,偶尔也用于其他分枝杆菌感染。了解上述罕见副作用可能有助于对此类病例进行临床评估和管理,包括避免不必要的剖腹探查。

相似文献

1
Intra-abdominal, crystal-storing histiocytosis due to clofazimine in a patient with lepromatous leprosy and concurrent carcinoma of the colon.氯法齐明致瘤型麻风并发结肠癌患者出现腹腔内晶体贮积性组织细胞增多症
Lepr Rev. 2004 Jun;75(2):171-6.
2
Clofazimine-induced crystal-storing histiocytosis producing chronic abdominal pain in a leprosy patient.氯法齐明诱发的晶体贮积性组织细胞增多症导致一名麻风病患者出现慢性腹痛。
Am J Surg Pathol. 2000 Jan;24(1):129-35. doi: 10.1097/00000478-200001000-00016.
3
[Persistent type 2 lepra reaction (erythema nodosum) and clofazimine-induced lethal enteropathy].[持续性2型麻风反应(结节性红斑)与氯法齐明诱导的致死性肠病]
Biomedica. 2009 Mar;29(1):18-24.
4
Clofazimine-induced enteropathy in a patient of leprosy.氯法齐明致麻风病患者肠病。
Indian J Pharmacol. 2013 Mar-Apr;45(2):197-8. doi: 10.4103/0253-7613.108323.
5
Clofazimine induced enteropathy--a case highlighting the importance of drug induced disease in differential diagnosis.氯法齐明引起的肠病——一例凸显药物性疾病在鉴别诊断中重要性的病例
Trop Gastroenterol. 2006 Apr-Jun;27(2):87-8.
6
Aplastic anaemia associated with multidrug therapy (dapsone, rifampicin and clofazimine) in a patient with lepromatous leprosy.一名瘤型麻风患者在接受多药联合治疗(氨苯砜、利福平及氯法齐明)后出现再生障碍性贫血。
Lepr Rev. 2005 Jun;76(2):167-9.
7
An unusual cause of small-intestine mucosal pigmentation.小肠黏膜色素沉着的一种罕见病因。
Gastrointest Endosc. 2011 Jun;73(6):1285-6. doi: 10.1016/j.gie.2010.12.031. Epub 2011 Feb 26.
8
[Late-occurring cutaneous vasculitis after successful treatment of diffuse lepromatous leprosy: Lucio's phenomenon].[弥漫性瘤型麻风成功治疗后迟发性皮肤血管炎:卢西奥现象]
Med Trop (Mars). 2007 Feb;67(1):65-8.
9
Tissue concentration, systemic distribution and toxicity of clofazimine--an autopsy study.氯法齐明的组织浓度、全身分布及毒性——一项尸检研究
Indian J Pathol Microbiol. 2004 Apr;47(2):281-3.
10
Chromoblastomycosis in a case of borderline lepromatous leprosy with recurrent type II lepra reaction.一例边缘型瘤型麻风伴反复Ⅱ型麻风反应患者发生的着色芽生菌病。
Lepr Rev. 2011 Sep;82(3):310-5.

引用本文的文献

1
Crystal-Storing Histiocytosis: The Iceberg of More Serious Conditions.晶体储存性组织细胞增多症:更严重病症的冰山一角。
Diagnostics (Basel). 2023 Jan 11;13(2):271. doi: 10.3390/diagnostics13020271.
2
Immunoglobulin-Storing Histiocytosis: A Case Based Systemic Review.免疫球蛋白储存组织细胞增多症:基于病例的系统评价
J Clin Med. 2021 Apr 23;10(9):1834. doi: 10.3390/jcm10091834.
3
Nonimmunoglobulin Crystal-Storing Histiocytosis (CSH): Case Report and Literature Review.非免疫球蛋白晶体储存组织细胞增多症(CSH):病例报告及文献综述
Case Rep Hematol. 2020 Oct 19;2020:8856411. doi: 10.1155/2020/8856411. eCollection 2020.
4
The subcellular distribution of small molecules: from pharmacokinetics to synthetic biology.小分子的亚细胞分布:从药代动力学到合成生物学。
Mol Pharm. 2011 Oct 3;8(5):1619-28. doi: 10.1021/mp200092v. Epub 2011 Aug 15.